News
Drug produces mixed results in myelofibrosis
- Author:
- HT Staff
Two phase 3 trials have shown mixed results in myelofibrosis (MF) patients receiving the JAK inhibitor momelotinib, according to Gilead Sciences,...
News
AACN releases updated resource on VTE
- Author:
- HT Staff
caring for a patient in an intensive care unit The American Association of Critical-Care Nurses (AACN) has released updated resources aimed at...
News
Eligible patients aren’t receiving anticoagulants
- Author:
- HT Staff
NEW ORLEANS—Many US patients who are candidates for treatment with oral anticoagulants (OACs) are not actually receiving these drugs, a large...
News
Biomaterial stops bleeding, doesn’t rely on thrombosis
- Author:
- HT Staff
Photo courtesy of USDA Bioengineers have developed an injectable material that may provide a better way to stop bleeding in injured patients,...
News
Device provides long-lasting drug delivery
- Author:
- HT Staff
with 6 arms that can be folded and encased in a capsule. Photo by Melanie Gonick/MIT A new device can provide long-term, controlled drug release...
News
Compound could treat leukemia, other cancers
- Author:
- HT Staff
and Patrick Harran with a model of DZ-2384 Photo courtesy of Reed Hutchinson/UCLA A new compound holds promise for treating leukemia and other...
News
Anticoagulant therapies appear comparable
- Author:
- HT Staff
Photo from Business Wire NEW ORLEANS—Two types of anticoagulant therapy produce comparable outcomes for patients undergoing percutaneous coronary...
News
Hemophilia treatment falling short, study suggests
- Author:
- HT Staff
Results of a real-world, retrospective study suggest there may be a need to improve the standard of care for hemophilia A and B in some European...
News
Company withdraws application for eryaspase in ALL
- Author:
- HT Staff
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) asked for additional data on eryaspase, but ERYTECH...
News
Study shows lower bleeding risk with rivaroxaban
- Author:
- HT Staff
NEW ORLEANS—Results of the PIONEER AF-PCI trial suggest certain patients may have a lower risk of bleeding if they receive rivaroxaban rather than...
News
Team develops model of common infant ALL
- Author:
- HT Staff
Photo by Petr Kratochvil After trying for nearly 2 decades, researchers have created a mouse model of t(4;11) pro-B acute lymphoblastic leukemia...
News
Antiplatelet drugs produce similar results in PAD
- Author:
- HT Staff
Photo from AstraZeneca NEW ORLEANS—Results of the EUCLID trial suggest ticagrelor does not a provide a benefit over clopidogrel in patients with...
News
EMA recommends orphan status for drug in AML
- Author:
- HT Staff
The European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has recommended that BP1001 receive orphan designation as a...
News
FDA grants priority review for midostaurin
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has granted priority review for the new drug application for midostaurin (PKC412) as a treatment for...
News
MRI detects early stages of MF in mice
- Author:
- HT Staff
Magnetic resonance imaging (MRI) can effectively detect myelofibrosis (MF) in a mouse model, according to research published in the journal Blood...